Barclays lowered the firm’s price target on Archer Daniels (ADM) to $56 from $60 and keeps an Underweight rating on the shares. The company held its 3Q conference call, highlighting continued pressures in crush, biofuel regulatory uncertainties, and ongoing weakness in Human Nutrition, resulting in management affirming last month’s downward guidance revision, the analyst tells investors in a research note.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADM:
- Biden admin won’t finalize clean fuel guidance before exit, Reuters reports
- Archer Daniels Midland Schedules Investor Conference Call
- Archer Daniels reports Q3 adjusted EPS $1.09, consensus $1.09
- Archer Daniels backs FY24 EPS view $4.50-$5.00, consensus $4.60
- Archer Daniels options imply 1.5% move in share price post-earnings